Search research articles
Contact Us
Filters
Showing results (41-50 of 121) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
April 17, 2004
The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells
Karin Tarte, Michel Jourdan, Jean Luc Veyrune, et al.
Molecular Cancer Therapeutics
|
October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors
Jérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One
|
May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells
Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Oncogene
|
April 24, 2002
Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells
Yue Dan Wang, John De Vos, Michel Jourdan, et al.
Blood
|
October 25, 2003
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis
Karène Mahtouk, Michel Jourdan, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine
Tobias Meissner, Anja Seckinger, Thierry Rème, et al.
Journal of Hematology & Oncology
|
April 19, 2015
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma
Arnold Bolomsky, Dirk Hose, Martin Schreder, et al.
Srpski Arhiv Za Celokupno Lekarstvo
|
February 23, 2012
The role of fluorescence in situ hybridization and gene expression profiling in myeloma risk stratification
Dirk Hose, Anja Seckinger, Anna Jauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study
Guillaume Cartron, Lu Zhao-Yang, Marion Baudard, et al.
BMC Bioinformatics
|
January 15, 2008
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments
Thierry Rème, Dirk Hose, John De Vos, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 121) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
April 17, 2004
The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells
Karin Tarte, Michel Jourdan, Jean Luc Veyrune, et al.
Molecular Cancer Therapeutics
|
October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors
Jérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One
|
May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells
Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Oncogene
|
April 24, 2002
Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells
Yue Dan Wang, John De Vos, Michel Jourdan, et al.
Blood
|
October 25, 2003
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis
Karène Mahtouk, Michel Jourdan, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine
Tobias Meissner, Anja Seckinger, Thierry Rème, et al.
Journal of Hematology & Oncology
|
April 19, 2015
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma
Arnold Bolomsky, Dirk Hose, Martin Schreder, et al.
Srpski Arhiv Za Celokupno Lekarstvo
|
February 23, 2012
The role of fluorescence in situ hybridization and gene expression profiling in myeloma risk stratification
Dirk Hose, Anja Seckinger, Anna Jauch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study
Guillaume Cartron, Lu Zhao-Yang, Marion Baudard, et al.
BMC Bioinformatics
|
January 15, 2008
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments
Thierry Rème, Dirk Hose, John De Vos, et al.
Page
of 13